Affiliations 

  • 1 School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland. Electronic address: dineshp@uef.fi
  • 2 Pharmaceutical Sciences Laboratory, Faculty of Science & Engineering, Åbo Akademi University, 20500 Turku, Finland; Biomedical Engineering Department, Faculty of Engineering and Architecture, İzmir Katip Çelebi University, İzmir, Turkey
  • 3 School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland
  • 4 Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China
  • 5 Department of Chemistry, Fudan University, Shanghai, China
  • 6 School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia
  • 7 Departamento de Química Orgánica, Facultad de Química, Pontificia Universidad Católica de Chile, Av. Vicuña McKenna 4860, Macul, Santiago 7820436, Chile
  • 8 School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County Londonderry, Northern Ireland BT52 1SA, UK
  • 9 School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India
  • 10 Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University, Faculty of Pharmacy, Irbid 566, Jordan
  • 11 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia; School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales (NSW) 230, Australia
  • 12 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Malaysia
  • 13 Department of Metallurgical & Materials Engineering National Institute of Technology, Rourkela, Odisha 769008, India
  • 14 Uttar Pradesh University of Medical Sciences SAIFAI, Etawah 206130, India
  • 15 Shramshakti College of Food Technology, Maldad, Sangamner, Ahmednagar, Maharashtra 422608, India
  • 16 Pharmaceutical Sciences Laboratory, Faculty of Science & Engineering, Åbo Akademi University, 20500 Turku, Finland. Electronic address: jerosenh@abo.fi
Int J Pharm, 2020 Aug 30;586:119531.
PMID: 32540348 DOI: 10.1016/j.ijpharm.2020.119531

Abstract

This review details the antimicrobial applications of inorganic nanomaterials of mostly metallic form, and the augmentation of activity by surface conjugation of peptide ligands. The review is subdivided into three main sections, of which the first describes the antimicrobial activity of inorganic nanomaterials against gram-positive, gram-negative and multidrug-resistant bacterial strains. The second section highlights the range of antimicrobial peptides and the drug resistance strategies employed by bacterial species to counter lethality. The final part discusses the role of antimicrobial peptide-decorated inorganic nanomaterials in the fight against bacterial strains that show resistance. General strategies for the preparation of antimicrobial peptides and their conjugation to nanomaterials are discussed, emphasizing the use of elemental and metallic oxide nanomaterials. Importantly, the permeation of antimicrobial peptides through the bacterial membrane is shown to aid the delivery of nanomaterials into bacterial cells. By judicious use of targeting ligands, the nanomaterial becomes able to differentiate between bacterial and mammalian cells and, thus, reduce side effects. Moreover, peptide conjugation to the surface of a nanomaterial will alter surface chemistry in ways that lead to reduction in toxicity and improvements in biocompatibility.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.